Cargando…

Paraoxonase-1 and -3 Protein Expression in the Brain of the Tg2576 Mouse Model of Alzheimer’s Disease

Background: Brain oxidative lipid damage and inflammation are common in neurodegenerative diseases such as Alzheimer’s disease (AD). Paraoxonase-1 and -3 (PON1 and PON3) protein expression was demonstrated in tissue with no PON1 or PON3 gene expression. In the present study, we examine differences i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salazar, Jose Gregorio, Marsillach, Judit, Reverte, Ingrid, Mackness, Bharti, Mackness, Michael, Joven, Jorge, Camps, Jordi, Colomina, Maria Teresa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996151/ https://www.ncbi.nlm.nih.gov/pubmed/33668379 http://dx.doi.org/10.3390/antiox10030339

Ejemplares similares

Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease
por: Marsillach, Judit, et al.
Publicado: (2009)

Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment
por: Marsillach, Judit, et al.
Publicado: (2010)

Paraoxonase-1 Inhibits Oxidized Low-Density Lipoprotein-Induced Metabolic Alterations and Apoptosis in Endothelial Cells: A Nondirected Metabolomic Study
por: García-Heredia, Anabel, et al.
Publicado: (2013)

Paraoxonase-1 Is Not Associated with Coronary Artery Calcification in Type 2 Diabetes: Results from the PREDICT Study
por: Mackness, Bharti, et al.
Publicado: (2012)

Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease
por: Mackness, Bharti, et al.
Publicado: (2013)

Misconceptions about paraoxonase-1
por: Mackness, Michael, et al.
Publicado: (2021)

Methodological constraints in interpreting serum paraoxonase-1 activity measurements: an example from a study in HIV-infected patients
por: Parra, Sandra, et al.
Publicado: (2010)

Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis
por: Zuin, Marco, et al.
Publicado: (2022)

Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides
por: Mastorikou, M, et al.
Publicado: (2008)

Trehalose Improves Cognition in the Transgenic Tg2576 Mouse Model of Alzheimer’s Disease
por: Portbury, Stuart D., et al.
Publicado: (2017)

Neuritin Attenuates Cognitive Function Impairments in Tg2576 Mouse Model of Alzheimer's Disease
por: Choi, Yoori, et al.
Publicado: (2014)

A Novel Form of Compensation in the Tg2576 Amyloid Mouse Model of Alzheimer’s Disease
por: Somogyi, Attila, et al.
Publicado: (2016)

Examining the role of paraoxonase 2 in the dopaminergic system of the mouse brain
por: Garrick, Jacqueline M., et al.
Publicado: (2022)

Iron Chelation Inhibits Osteoclastic Differentiation In Vitro and in Tg2576 Mouse Model of Alzheimer’s Disease
por: Guo, Jun-Peng, et al.
Publicado: (2015)

Decreased Myelinated Fibers in the Hippocampal Dentate Gyrus of the Tg2576 Mouse Model of Alzheimer’s Disease
por: Lu, Wei, et al.
Publicado: (2016)

Quantitative study of the capillaries within the white matter of the Tg2576 mouse model of Alzheimer's disease
por: Zhang, Yi, et al.
Publicado: (2019)

Environmental enrichment does not influence hypersynchronous network activity in the Tg2576 mouse model of Alzheimer’s disease
por: Bezzina, Charlotte, et al.
Publicado: (2015)

Modifications of Hippocampal Circuits and Early Disruption of Adult Neurogenesis in the Tg2576 Mouse Model of Alzheimer’s Disease
por: Krezymon, Alice, et al.
Publicado: (2013)

Paraoxonase-1 and Other HDL Accessory Proteins in Neurological Diseases
por: Marsillach, Judit, et al.
Publicado: (2021)

Exploring the Role of Paraoxonases in the Pathogenesis of Coronary Artery Disease: A Systematic Review
por: Abelló, David, et al.
Publicado: (2014)

Analysis of differential plaque depositions in the brains of Tg2576 and Tg-APPswe/PS1dE9 transgenic mouse models of Alzheimer disease
por: Kim, Tae-Kyung, et al.
Publicado: (2012)

Defined astrocytic expression of human amyloid precursor protein in Tg2576 mouse brain
por: Heiland, Tina, et al.
Publicado: (2018)

Mitochondrial Superoxide Contributes to Blood Flow and Axonal Transport Deficits in the Tg2576 Mouse Model of Alzheimer's Disease
por: Massaad, Cynthia A., et al.
Publicado: (2010)

Characterization of hippocampal Cajal-Retzius cells during development in a mouse model of Alzheimer's disease (Tg2576)
por: Yu, Dongming, et al.
Publicado: (2014)

Oxidative Stress during the Progression of β-Amyloid Pathology in the Neocortex of the Tg2576 Mouse Model of Alzheimer's Disease
por: Porcellotti, Sara, et al.
Publicado: (2015)

Dysbiosis of Fecal Microbiota in Tg2576 Mice for Alzheimer’s Disease during Pathological Constipation
por: Kim, Ji-Eun, et al.
Publicado: (2022)

Age-related changes of protein SUMOylation balance in the AβPP Tg2576 mouse model of Alzheimer's disease
por: Nisticò, Robert, et al.
Publicado: (2014)

Spared Piriform Cortical Single-Unit Odor Processing and Odor Discrimination in the Tg2576 Mouse Model of Alzheimer's Disease
por: Xu, Wenjin, et al.
Publicado: (2014)

Cell Type-Specific Human APP Transgene Expression by Hippocampal Interneurons in the Tg2576 Mouse Model of Alzheimer’s Disease
por: Höfling, Corinna, et al.
Publicado: (2019)

Spatial and latent memory data in PS2Tg2576 alzheimer's disease mouse model after memantine treatment
por: Matsumura, Masahisa, et al.
Publicado: (2021)

Immunohistochemical Demonstration of the pGlu79 α-Synuclein Fragment in Alzheimer’s Disease and Its Tg2576 Mouse Model
por: Bluhm, Alexandra, et al.
Publicado: (2022)

Age-Dependent Neuroplasticity Mechanisms in Alzheimer Tg2576 Mice Following Modulation of Brain Amyloid-β Levels
por: Lilja, Anna M., et al.
Publicado: (2013)

Leaky Ryanodine receptors increases Amyloid-beta load and induces memory impairments in Tg2576 mouse model of Alzheimer disease
por: Oulès, Bénédicte, et al.
Publicado: (2013)

Early Onset of Hypersynchronous Network Activity and Expression of a Marker of Chronic Seizures in the Tg2576 Mouse Model of Alzheimer’s Disease
por: Bezzina, Charlotte, et al.
Publicado: (2015)

Up-regulation of Synaptotagmin IV within amyloid plaque-associated dystrophic neurons in Tg2576 mouse model of Alzheimer’s disease
por: Tratnjek, Larisa, et al.
Publicado: (2013)

Chronic treatment with a smart antioxidative nanoparticle for inhibition of amyloid plaque propagation in Tg2576 mouse model of Alzheimer’s disease
por: Boonruamkaew, Phetcharat, et al.
Publicado: (2017)

ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease
por: Evans, Charles E., et al.
Publicado: (2020)

Docosahexaenoic Acid Ameliorates Contextual Fear Memory Deficits in the Tg2576 Alzheimer’s Disease Mouse Model: Cellular and Molecular Correlates
por: Badesso, Sara, et al.
Publicado: (2022)

Influence of Transgenic Metallothionein-1 on Gliosis, CA1 Neuronal Loss, and Brain Metal Levels of the Tg2576 Mouse Model of Alzheimer’s Disease
por: Comes, Gemma, et al.
Publicado: (2017)

Correction: Age-Dependent Neuroplasticity Mechanisms in Alzheimer Tg2576 Mice Following Modulation of Brain Amyloid-β Levels
por: Lilja, Anna M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_va3k1m20e4ebkbu3sf0rcmef91